Supplemental Vitamins and Minerals for CVD Prevention and Treatment.

[1]  Mengmeng Du,et al.  Trends in Dietary Supplement Use Among US Adults From 1999-2012. , 2016, JAMA.

[2]  H. Bang,et al.  Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  J. Spence,et al.  Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke. , 2016, Nutrition research.

[4]  S. Daskalopoulou,et al.  Potential factors associated with fruit and vegetable intake after premature acute coronary syndrome: a prospective cohort study , 2015, International journal of food sciences and nutrition.

[5]  Zan Ding,et al.  Efficacy of Supplementation with B Vitamins for Stroke Prevention: A Network Meta-Analysis of Randomized Controlled Trials , 2015, PloS one.

[6]  A. Uitterlinden,et al.  Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial , 2015, Journal of hypertension.

[7]  Li-sheng Liu,et al.  Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. , 2015, JAMA.

[8]  Zhi-Yong Wang,et al.  Association between B Vitamins Supplementation and Risk of Cardiovascular Outcomes: A Cumulative Meta-Analysis of Randomized Controlled Trials , 2014, PloS one.

[9]  J. Manson,et al.  Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians' Health Study II randomized trial. , 2014, The American journal of clinical nutrition.

[10]  Darrel P Francis,et al.  Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients , 2014, BMJ : British Medical Journal.

[11]  Sarah Parish,et al.  Effects of extended-release niacin with laropiprant in high-risk patients. , 2014, The New England journal of medicine.

[12]  J. Fleg,et al.  Safety profile of extended-release niacin in the AIM-HIGH trial. , 2014, The New England journal of medicine.

[13]  V. Moyer,et al.  Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive services Task Force recommendation statement. , 2014, Annals of internal medicine.

[14]  Jennifer S. Lin,et al.  Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force , 2013, Annals of Internal Medicine.

[15]  R. Peto,et al.  Vitamin A supplementation in Indian children – Authors' reply , 2013, The Lancet.

[16]  E. Mayo-Wilson,et al.  Vitamin A supplementation in Indian children , 2013, The Lancet.

[17]  Gordon H Guyatt,et al.  GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. , 2013, Journal of clinical epidemiology.

[18]  G. Guyatt,et al.  GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. , 2013, Journal of clinical epidemiology.

[19]  G. Guyatt,et al.  GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. , 2013, Journal of clinical epidemiology.

[20]  Elie A Akl,et al.  GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. , 2013, Journal of clinical epidemiology.

[21]  M. Gail,et al.  Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. , 2012, Journal of the National Cancer Institute.

[22]  M. Stampfer,et al.  Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses. , 2011, JAMA.

[23]  William Weintraub,et al.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. , 2011, The New England journal of medicine.

[24]  G. Guyatt,et al.  GRADE guidelines 6. Rating the quality of evidence--imprecision. , 2011, Journal of clinical epidemiology.

[25]  G. Guyatt,et al.  GRADE guidelines: 8. Rating the quality of evidence--indirectness. , 2011, Journal of clinical epidemiology.

[26]  Gordon H Guyatt,et al.  GRADE guidelines: 7. Rating the quality of evidence--inconsistency. , 2011, Journal of clinical epidemiology.

[27]  Gordon H Guyatt,et al.  GRADE guidelines: 9. Rating up the quality of evidence. , 2011, Journal of clinical epidemiology.

[28]  Gordon H Guyatt,et al.  GRADE guidelines: 5. Rating the quality of evidence--publication bias. , 2011, Journal of clinical epidemiology.

[29]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[30]  J. Crowley,et al.  Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial ( SELECT ) , 2011 .

[31]  Howard Balshem,et al.  GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.

[32]  G. Guyatt,et al.  GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). , 2011, Journal of clinical epidemiology.

[33]  Gordon H Guyatt,et al.  GRADE guidelines: 2. Framing the question and deciding on important outcomes. , 2011, Journal of clinical epidemiology.

[34]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[35]  P. Galan,et al.  Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial , 2010, BMJ : British Medical Journal.

[36]  M. Touvier,et al.  Incidence of cancers, ischemic cardiovascular diseases and mortality during 5‐year follow‐up after stopping antioxidant vitamins and minerals supplements: A postintervention follow‐up in the SU.VI.MAX Study , 2010, International journal of cancer.

[37]  G. Hankey.  B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial , 2010, The Lancet Neurology.

[38]  R. Collins,et al.  Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. , 2010, JAMA.

[39]  Ross J. Harris,et al.  Circulating Folate, Vitamin B12, Homocysteine, Vitamin B12 Transport Proteins, and Risk of Prostate Cancer: a Case-Control Study, Systematic Review, and Meta-analysis , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[40]  D. Churchill,et al.  Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. , 2010, JAMA.

[41]  J. Heinz,et al.  B Vitamins and the Risk of Total Mortality and Cardiovascular Disease in End-Stage Renal Disease: Results of a Randomized Controlled Trial , 2010, Circulation.

[42]  W. Willett,et al.  A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. , 2009, The American journal of clinical nutrition.

[43]  F. Clavel-Chapelon,et al.  Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study , 2009, European Journal of Clinical Nutrition.

[44]  Fei Wang,et al.  Combined use of extended-release niacin and atorvastatin: safety and effects on lipid modification. , 2009, Chinese medical journal.

[45]  J. H. Baron.  Sailors' scurvy before and after James Lind--a reassessment. , 2009, Nutrition reviews.

[46]  E. Lonn,et al.  Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability: Additional Findings From the HOPE 2 Trial , 2009, Stroke.

[47]  A. Schatzkin,et al.  Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. , 2009, Archives of internal medicine.

[48]  M. Imasa,et al.  Folic Acid-Based Intervention in Non-ST Elevation Acute Coronary Syndromes , 2009, Asian cardiovascular & thoracic annals.

[49]  J. Crowley,et al.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2009, JAMA.

[50]  S. Vollset,et al.  Angiography : A Randomized Controlled Trial CoronaryWith Homocysteine-Lowering B Vitamins After Mortality and Cardiovascular Events in Patients Treated , 2008 .

[51]  N. Wareham,et al.  Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance , 2008, Diabetes.

[52]  J. Manson,et al.  Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. , 2008, JAMA.

[53]  P. Guarino,et al.  Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. , 2007, JAMA.

[54]  J. Manson,et al.  A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. , 2007, Archives of internal medicine.

[55]  Elizabeth L. Barry,et al.  Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. , 2007, JAMA.

[56]  Amy Subar,et al.  Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. , 2007, Journal of the National Cancer Institute.

[57]  T. Matsuo,et al.  Uremic hyperhomocysteinemia: A randomized trial of folate treatment for the prevention of cardiovascular events , 2007, Hemodialysis international. International Symposium on Home Hemodialysis.

[58]  R. Peto,et al.  Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double‐blind trial , 2007, Journal of internal medicine.

[59]  M. Plummer,et al.  Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population. , 2007, Journal of the National Cancer Institute.

[60]  Per Magne Ueland,et al.  Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.

[61]  R. Hoover,et al.  Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. , 2006, The American journal of clinical nutrition.

[62]  J. McNeil,et al.  Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. , 2006, Journal of the American College of Cardiology.

[63]  Deliang Tang,et al.  Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[64]  J. Tijssen,et al.  Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial. , 2004, International journal of cardiology.

[65]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[66]  Nea Malila,et al.  Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. , 2003, JAMA.

[67]  A. Zwinderman,et al.  Secondary prevention with folic acid: effects on clinical outcomes. , 2003, Journal of the American College of Cardiology.

[68]  A. Sessa,et al.  Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[69]  J. Hsia,et al.  Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial , 2002 .

[70]  Tw.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002, The Lancet.

[71]  R. Collins,et al.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[72]  N. Brown,et al.  The Roche European American Cataract Trial (REACT): A randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract , 2002, Ophthalmic epidemiology.

[73]  E. Bolson,et al.  Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. , 2001, The New England journal of medicine.

[74]  M. Gail,et al.  Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2001, Journal of the National Cancer Institute.

[75]  J. Jacobson,et al.  Effects of a 6-month vitamin intervention on DNA damage in heavy smokers. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[76]  T. Lakka,et al.  Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3‐year progression of carotid atherosclerosis , 2000, Journal of internal medicine.

[77]  J. Faivre,et al.  Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial , 2000, The Lancet.

[78]  P. Galan,et al.  Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. , 1999, Archives of internal medicine.

[79]  R Bender,et al.  Multiple test procedures other than Bonferroni's deserve wider use , 1999, BMJ.

[80]  M. Spittle,et al.  Women remain confused about breast cancer , 1999, BMJ.

[81]  G. Beck,et al.  Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. , 1999, The New England journal of medicine.

[82]  J. Cerhan,et al.  A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[83]  P. Galan,et al.  Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. , 1997, Annals of nutrition & metabolism.

[84]  S. Ross.  The CONSORT statement. , 1996, JAMA.

[85]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[86]  W. R. Bruce,et al.  A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. , 1988, Cancer research.

[87]  J. Stamler.  Clofibrate and niacin in coronary heart disease. , 1975, JAMA.

[88]  A. Act.  Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients , 2014 .

[89]  H. Schünemann,et al.  [GRADE guidelines: 9. Rating up the quality of evidence]. , 2013, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[90]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[91]  C. Bias.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials , 2011 .

[92]  K. Muir,et al.  Aspirin and folic acid for the prevention of recurrent colorectal adenomas. , 2008, Gastroenterology.

[93]  A. Berg.  U.S. Preventive Services Task Force , 2004 .

[94]  A. Coats.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[95]  B. Aa,et al.  Re: Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pylori Therapy , 2001 .

[96]  Dean P. Jones,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. , 2001, Archives of ophthalmology.

[97]  M. Gail,et al.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2000, Journal of the National Cancer Institute.

[98]  ummers,et al.  CALCIUM SUPPLEMENTS FOR THE PREVENTION OF COLORECTAL ADENOMAS , 2000 .